Texas Children’s Hospital agrees to settlement that ends pediatric gender-affirming procedures and creates a new detransition clinic
Houston — Texas Children’s Hospital has reached a landmark settlement with the U.S. Department of Justice and the Texas attorney general’s office that will end the hospital’s provision of pediatric gender-affirming procedures and require it to fund what officials describe as the nation’s first dedicated detransition clinic.
The agreement, announced Friday, resolves a yearslong investigation into allegations that the Houston-based children’s hospital violated federal law and Texas restrictions by providing puberty blockers, cross-sex hormones and related interventions to minors. Under the terms outlined by the Justice Department, Texas Children’s will also pay more than $10 million in damages and civil penalties while committing to stop offering the contested treatments to children.
Federal officials said the settlement marks the first resolution in an ongoing national inquiry into whether some providers improperly billed government and private insurance plans for pediatric sex-rejecting procedures. The Justice Department said the hospital’s conduct allegedly implicated the Federal Food, Drug, and Cosmetic Act, the False Claims Act and federal fraud and conspiracy statutes.
Texas Children’s Hospital did not immediately issue a detailed public response to the settlement terms, but officials in the case said the institution cooperated with investigators and took steps that helped bring the matter to a close. The agreement is expected to have wide-reaching implications for other hospitals and clinics that have provided gender-affirming medical care to minors, particularly in states where the legality of those services has been contested.
Investigation centered on alleged secret continuation of care
The investigation had reportedly been underway for years, fueled in part by whistleblower allegations that the hospital continued providing gender-related procedures to minors even after Texas lawmakers moved to restrict such care. Supporters of the probe argued that public providers could not legally continue offering treatments they believed were barred under state law.
According to officials, the settlement requires Texas Children’s to permanently stop administering puberty blockers and cross-sex hormones to minors. The hospital must also work with authorities on the creation of a multidisciplinary detransition clinic, a new type of facility intended to provide restorative care to individuals who say they were harmed by prior gender-transition treatment.
That clinic will be funded by Texas Children’s, the largest children’s hospital system in the country, and is expected to provide services free of charge for the first five years. Officials said the center will address medical and psychological needs that may arise after a patient discontinues transition-related care or seeks treatment for complications from prior interventions.
The Justice Department said the arrangement was reached in coordination with Texas Attorney General Ken Paxton. Paxton’s office had separately been pursuing the hospital over allegations that it violated state law and misled insurers. The state and federal cases were resolved together as part of the broader agreement.
Millions in penalties and restrictions on physicians
Under the settlement, Texas Children’s will pay more than $10 million in civil penalties and damages to settle allegations that it submitted false claims to Medicaid and other insurers. Officials said the payments are intended to resolve accusations that billing practices were used to secure coverage for treatments the government now says should not have been provided to children.
The agreement also calls for the permanent termination and revocation of privileges for five physicians who performed the procedures covered by the investigation. That provision is likely to intensify debate over the role of individual clinicians in delivering contested forms of pediatric care and the extent to which hospitals must police their medical staff when policies shift.
Advocates for restrictions on youth gender-affirming care portrayed the announcement as a major victory and a warning to other institutions. They have long argued that minors should not receive medical interventions that alter puberty or change hormone levels while they are still developing physically and emotionally.
Supporters of gender-affirming care, however, say such treatments are medically appropriate in some cases and can be life-saving for transgender youth. They have criticized efforts to prohibit or penalize providers, arguing that decisions about care should be made by families and doctors rather than courts and politicians. The settlement is likely to deepen that national divide.
National implications for pediatric gender care
The case arrives at a moment of intense legal and political conflict over youth gender medicine. In statehouses, federal courts and hospital boardrooms, the issue has become one of the most contentious in American health care. Several states have enacted bans or severe restrictions on gender-affirming treatments for minors, while others have taken steps to protect access.
For Texas Children’s, the outcome could bring an end to a high-profile investigation that had put the hospital under significant legal and public scrutiny. It also places the institution at the center of a broader national conversation about what care should be available for transgender adolescents and how health systems should respond when laws change.
Officials familiar with the case said the new detransition clinic is intended to serve patients who want medical support after stopping gender-transition treatment. That concept, though still relatively rare in the U.S. health care system, has become a point of emphasis among critics of pediatric gender medicine, who say clinics like this are necessary to assist people they believe were harmed by earlier interventions.
It remains unclear how many patients may seek treatment at the clinic or what services it will ultimately provide beyond general restorative care. Details about staffing, referral pathways and the timeline for opening the clinic were not immediately released.
Still, the settlement sends a powerful signal. By combining financial penalties, practice restrictions and a new clinic for detransition care, the agreement represents one of the most consequential government actions yet in the national dispute over how children experiencing gender dysphoria should be treated.
As the legal and medical debate continues, hospitals across the country are likely to study the Texas Children’s resolution closely. Whether it becomes a template for similar agreements elsewhere — or a flashpoint in the ongoing battle over transgender health policy — may depend on how regulators, courts and medical institutions respond in the months ahead.